| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8959031 | Biological Psychiatry | 2018 | 51 Pages |
Abstract
Neuronal cell death-specific treatment approaches, such as P7C3 compounds, may represent a new treatment approach for patients experiencing the combination of cognitive deficits and depression associated with AD.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Jaymie R. Voorhees, Matthew T. Remy, Coral J. Cintrón-Pérez, Eli El Rassi, Michael Z. Khan, Laura M. Dutca, Terry C. Yin, Latisha N. McDaniel, Noelle S. Williams, Daniel J. Brat, Andrew A. Pieper,